The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study

The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study

Abstract Background The neutrophil-lymphocyte ratio (NLR) is a well-known prognostic marker in various cancers. However, its role as a predictive marker for the effectiveness of nivolumab in patients with metastatic RCC (mRCC) remains unclear. We evaluated the relationships between the NLR and progr...

Full description

Bibliographic Details
Main Authors: Naotaka Nishiyama, Megumi hirobe, Takuya Kikushima, Masahiro Matsuki, Atsushi Takahashi, Masahiro Yanase, Keisuke Ichimatsu, Masayuki Egawa, Norihiro Hayashi, Takahito Negishi, Naoya Masumori, Hiroshi Kitamura
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Urology
Subjects:
Metastatic renal cell carcinoma
Nivolumab
Neutrophil-lymphocyte ratio
Online Access:http://link.springer.com/article/10.1186/s12894-020-00679-2

Internet

http://link.springer.com/article/10.1186/s12894-020-00679-2

Similar Items